The new mining toolbox will start slow worldwide, but as the pipelines fill with new opportunities that microbial access facilitates adoption, and technology advances will accelerate. It is likely, in short order, 3-5 years, that new opportunities in therapeutics will impact rare and orphan diseases as well. Other life science areas will also benefit, including agrochemicals, sustainability, remediation, carbon capture, advanced energy, and cosmetics. Within ten years of execution and widespread adoption, most pipelines will be traced to the opportunity of untapped microbes of the earth.
White Paper
Biosortia is continually expanding it’s novel library of small molecules (SMs) directly from natural microbiomes. Novel SMs from naturally occurring microbes in microbiomes are biologically pre-optimized as the best sources of life science starting points. Activities of these small molecules are grouped in well plates according to machine learning for artificial intelligence prioritization or sorted and organized by initial screening activity potential.
Biosortia out licenses its exclusive database on natural microbiomes to assist organizations applying machine learning and artificial intelligence for obtaining solutions, prioritization, modeling, projections, and other opportunities. Data includes environmental, habitat, species, metagenomic, genomic, metabolic pathways, gene cluster, known and novel small molecules (SMs), activities based on screening and computational analysis of (SMs). Biosortia is providing much needed missing datasets for discovery.
Biosortia makes available rare small molecules (SMs) made from microorganisms (bacteria, fungi, archaea, & viruses) in natural microbiomes. We specialize in the ‘hard to obtain’ or large quantities by special request for rare SMs. Please provide details about your needs. Our datasets should be able to determine the producing species. Our SM library may also have isomers or natural derivatives available.
Biosortia’s scientifically validated technology platforms and systems distinctly capture never-before accessed natural microbiomes’ critical data and novel small molecules. Biosortia’s full scale microbiome harvesting, and mining platform is positioned to disrupt and transform knowledge. Consider Biosortia and our world-renowned PhDs and partners for grant participation, and commercialization.
Duns #832707629 / Cage # 5TA50